Concepedia

Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease

Agnieszka Gawrońska, Marcin Banasiuk, D Lachowicz, Hanna Pituch, Piotr Albrecht, Aleksandra Banaszkiewicz

Inflammatory Bowel Diseases · 2017 · 24 citations · 27 references

DOIFull text

Open access

Abstract

Metronidazole and rifaximin were similarly effective treatments for CDI in pediatric patients with IBD.

References

27

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

Stuart H. Cohen, Dale N. Gerding, Stuart Johnson et al. · Infection Control and Hospital Epidemiology · 2010 · 2.9K citations

, , +15

ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

Arie Levine, Sibylle Koletzko, Dan Turner et al. · Journal of Pediatric Gastroenterology and Nutrition · 2013 · 1.3K citations · Full text

Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec

Jean‐Louis Pépin, Nabil Saheb, Marie‐Andrée Coulombe et al. · Clinical Infectious Diseases · 2005 · 994 citations

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Jean‐François Rahier, Fernando Magro, Cândida Abreu et al. · Journal of Crohn s and Colitis · 2014 · 909 citations · Full text

Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients

Colleen Kelly, Chioma Ihunnah, Monika Fischer et al. · The American Journal of Gastroenterology · 2014 · 634 citations · Full text